Skip to main content
Top
Published in: BMC Public Health 1/2001

Open Access 01-12-2001 | Study protocol

A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology

Authors: Liam Smeeth, Andrew J Hall, Eric Fombonne, Laura C Rodrigues, Xiangning Huang, Peter G Smith

Published in: BMC Public Health | Issue 1/2001

Login to get access

Abstract

Background

An association between mumps-measles-rubella (MMR) vaccination and the onset of symptoms typical of autism has recently been suggested. This has led to considerable concern about the safety of the vaccine.

Methods

A matched case-control study using data derived form the United Kingdom General Practice Research Database. Children with a possible diagnosis of autism will be identified from their electronic health records. All diagnoses will be validated by a detailed review of hospital letters and by using information derived from a parental questionnaire. Ten controls per case will be selected from the database. Conditional logistic regression will be used to assess the association between MMR vaccination and autism. In addition case series analyses will be undertaken to estimate the relative incidence of onset of autism in defined time intervals after vaccination. The study is funded by the United Kingdom Medical Research Council.

Discussion

Electronic health databases offer tremendous opportunities for evaluating the adverse effects of vaccines. However there is much scope for bias and confounding. The rigorous validation of all diagnoses and the collection of additional information by parental questionnaire in this study are essential to minimise the possibility of misleading results.
Literature
1.
go back to reference World Health Organisation: The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organisation;. 1992 World Health Organisation: The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organisation;. 1992
3.
go back to reference Volkmar FR, Klin A, Siegel B, Szatmari P, Lord C, Campbell M, et al: Field trial for autistic disorder in DSM-IV. Am J Psychiatry. 1994, 151: 1361-1367.CrossRefPubMed Volkmar FR, Klin A, Siegel B, Szatmari P, Lord C, Campbell M, et al: Field trial for autistic disorder in DSM-IV. Am J Psychiatry. 1994, 151: 1361-1367.CrossRefPubMed
4.
go back to reference Rogers SJ, DiLalla DL: Age of symptom onset in young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 1990, 29: 863-872.CrossRefPubMed Rogers SJ, DiLalla DL: Age of symptom onset in young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 1990, 29: 863-872.CrossRefPubMed
5.
go back to reference De Giacomo A, Fombonne E: Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry. 1998, 7: 131-136. 10.1007/s007870050058.CrossRefPubMed De Giacomo A, Fombonne E: Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry. 1998, 7: 131-136. 10.1007/s007870050058.CrossRefPubMed
6.
go back to reference Fombonne E: The epidemiology of autism: a review. Psychol Med. 1999, 29: 769-786. 10.1017/S0033291799008508.CrossRefPubMed Fombonne E: The epidemiology of autism: a review. Psychol Med. 1999, 29: 769-786. 10.1017/S0033291799008508.CrossRefPubMed
7.
go back to reference Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998, 351: 637-641. 10.1016/S0140-6736(97)11096-0.CrossRefPubMed Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998, 351: 637-641. 10.1016/S0140-6736(97)11096-0.CrossRefPubMed
9.
10.
go back to reference Begg N, Ramsay M, White J, Bozoky Z: Media dents confidence in MMR vaccine. BMJ. 1998, 316: 561-CrossRef Begg N, Ramsay M, White J, Bozoky Z: Media dents confidence in MMR vaccine. BMJ. 1998, 316: 561-CrossRef
11.
go back to reference Thomas DR, Salmon RL, King J: Rates of first measles-mumps-rubella immunisation in Wales (UK). Lancet. 1998, 351: 1927-10.1016/S0140-6736(98)24026-8.CrossRefPubMed Thomas DR, Salmon RL, King J: Rates of first measles-mumps-rubella immunisation in Wales (UK). Lancet. 1998, 351: 1927-10.1016/S0140-6736(98)24026-8.CrossRefPubMed
12.
go back to reference Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al: Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000, 95: 2285-2295. 10.1016/S0002-9270(00)02041-4.CrossRefPubMed Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al: Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000, 95: 2285-2295. 10.1016/S0002-9270(00)02041-4.CrossRefPubMed
13.
go back to reference Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M: No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998, 351: 1327-1328. 10.1016/S0140-6736(98)24018-9.CrossRefPubMed Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M: No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998, 351: 1327-1328. 10.1016/S0140-6736(98)24018-9.CrossRefPubMed
14.
go back to reference Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000, 19: 1127-1134. 10.1097/00006454-200012000-00002.CrossRefPubMed Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H: Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000, 19: 1127-1134. 10.1097/00006454-200012000-00002.CrossRefPubMed
15.
16.
go back to reference Gillberg C, Heijbel H: MMR and autism. Autism. 1998 Gillberg C, Heijbel H: MMR and autism. Autism. 1998
17.
go back to reference Committee on Safety of Medicines: Report of the Working Party on MMR Vaccine. London, Committee on Safety of Medicines. 1999 Committee on Safety of Medicines: Report of the Working Party on MMR Vaccine. London, Committee on Safety of Medicines. 1999
18.
go back to reference Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al: Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999, 353: 2026-2029. 10.1016/S0140-6736(99)01239-8.CrossRefPubMed Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, et al: Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999, 353: 2026-2029. 10.1016/S0140-6736(99)01239-8.CrossRefPubMed
21.
go back to reference Loff B, Cordner S: Australia's measles campaign challenged. Lancet. 1998, 352: 1368-CrossRef Loff B, Cordner S: Australia's measles campaign challenged. Lancet. 1998, 352: 1368-CrossRef
24.
go back to reference Pareek M, Pattison HM: The two-dose measles, mumps and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Br J Gen Pract. 2000, 50: 969-971.PubMedPubMedCentral Pareek M, Pattison HM: The two-dose measles, mumps and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate. Br J Gen Pract. 2000, 50: 969-971.PubMedPubMedCentral
25.
go back to reference Petrovic M, Roberts R, Ramsay M: Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ. 2001, 322: 82-85. 10.1136/bmj.322.7278.82.CrossRefPubMedPubMedCentral Petrovic M, Roberts R, Ramsay M: Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ. 2001, 322: 82-85. 10.1136/bmj.322.7278.82.CrossRefPubMedPubMedCentral
26.
go back to reference Wakefield AJ, Montgomery SM: Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev. 2001, 19: 265-283. Wakefield AJ, Montgomery SM: Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev. 2001, 19: 265-283.
27.
go back to reference Walley T, Mantgani A: The UK General Practice Research Database. Lancet. 1997, 350: 1097-1099. 10.1016/S0140-6736(97)04248-7.CrossRefPubMed Walley T, Mantgani A: The UK General Practice Research Database. Lancet. 1997, 350: 1097-1099. 10.1016/S0140-6736(97)04248-7.CrossRefPubMed
28.
go back to reference Lawson DH, Sherman V, Hollowell J: The General Practice Research Database. Scientific and Ethical Advisory Group. Q J Med. 1998, 91: 445-452. 10.1093/qjmed/91.6.445.CrossRef Lawson DH, Sherman V, Hollowell J: The General Practice Research Database. Scientific and Ethical Advisory Group. Q J Med. 1998, 91: 445-452. 10.1093/qjmed/91.6.445.CrossRef
29.
go back to reference Office for National Statistics: Key health Statistics from general practice 1996 (Series MB6 No. 1). London: Office for National Statistics;. 1998 Office for National Statistics: Key health Statistics from general practice 1996 (Series MB6 No. 1). London: Office for National Statistics;. 1998
30.
go back to reference Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991, 302: 766-768.CrossRefPubMedPubMedCentral Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991, 302: 766-768.CrossRefPubMedPubMedCentral
31.
go back to reference Jick H, Terris BZ, Derby LE, Jick SS: Further validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Pharmacoepid Drug Safety. 1992, 347-349. Jick H, Terris BZ, Derby LE, Jick SS: Further validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Pharmacoepid Drug Safety. 1992, 347-349.
32.
33.
go back to reference van Staa T, Abenhaim L: The quality of information recorded on a UK database of primary care records: a study of hospitalisations due to hypoglycaemia and other conditions. Pharmacoepid Drug Safety. 1994, 3: 15-21.CrossRef van Staa T, Abenhaim L: The quality of information recorded on a UK database of primary care records: a study of hospitalisations due to hypoglycaemia and other conditions. Pharmacoepid Drug Safety. 1994, 3: 15-21.CrossRef
34.
go back to reference Hollowell J: The General Practice Research Database: quality of morbidity data. Popul Trends. 1997, 36-40. Hollowell J: The General Practice Research Database: quality of morbidity data. Popul Trends. 1997, 36-40.
35.
go back to reference Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD: Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol. 2000, 49: 591-596. 10.1046/j.1365-2125.2000.00199.x.CrossRefPubMedPubMedCentral Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD: Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol. 2000, 49: 591-596. 10.1046/j.1365-2125.2000.00199.x.CrossRefPubMedPubMedCentral
36.
go back to reference Berument SK, Rutter M, Lord C, Pickles A, Bailey A: Autism screening questionnaire: diagnostic validity. Br J Psychiatry. 1999, 175: 444-451.CrossRefPubMed Berument SK, Rutter M, Lord C, Pickles A, Bailey A: Autism screening questionnaire: diagnostic validity. Br J Psychiatry. 1999, 175: 444-451.CrossRefPubMed
37.
go back to reference Garcia Rodriguez LA, Ruigomez A, Jick H: A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy. 1997, 17: 721-728.PubMed Garcia Rodriguez LA, Ruigomez A, Jick H: A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy. 1997, 17: 721-728.PubMed
38.
go back to reference Wentz KR, Marcuse EK: Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics. 1991, 87: 287-297.PubMed Wentz KR, Marcuse EK: Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence. Pediatrics. 1991, 87: 287-297.PubMed
39.
go back to reference Peckham C: The Peckham report: national immunisation study. Institute of Child Health; London. 1989 Peckham C: The Peckham report: national immunisation study. Institute of Child Health; London. 1989
40.
go back to reference Farrington CP: Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995, 51: 228-235.CrossRefPubMed Farrington CP: Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995, 51: 228-235.CrossRefPubMed
41.
go back to reference Farrington CP, Nash J, Miller E: Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996, 143: 1165-1173.CrossRefPubMed Farrington CP, Nash J, Miller E: Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996, 143: 1165-1173.CrossRefPubMed
42.
go back to reference Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E: A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995, 345: 567-569. 10.1016/S0140-6736(95)90471-9.CrossRefPubMed Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E: A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995, 345: 567-569. 10.1016/S0140-6736(95)90471-9.CrossRefPubMed
43.
go back to reference Medical Research Council: Personal information in medical research. London: MRC;. 2000 Medical Research Council: Personal information in medical research. London: MRC;. 2000
44.
go back to reference General Medical Council: Confidentiality. London: GMC;. 2000 General Medical Council: Confidentiality. London: GMC;. 2000
Metadata
Title
A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology
Authors
Liam Smeeth
Andrew J Hall
Eric Fombonne
Laura C Rodrigues
Xiangning Huang
Peter G Smith
Publication date
01-12-2001
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2001
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-1-2

Other articles of this Issue 1/2001

BMC Public Health 1/2001 Go to the issue